FOXP4 and prostate carcinoma: One study showed that FOXP4 is involved in prostate cancer progression.25 In the present study, FOXP4 was overexpressed in prostate cancer, and miR‐1182 bound to FOXP4 and inhibited in expression in PC3 and DU145 prostate cancer cells.